GlassScriptPhysician profile
William F Sima
NPI 1770505505
$18,373.73
in general payments reported to CMS, 2019-2025
18 companies · $4,399 in 2025
The $4,399 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,366 · 2020: $134 · 2021: $2,407 · 2022: $3,405 · 2023: $2,481 · 2024: $3,182 · 2025: $4,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,994 · Travel and Lodging: $4,991 · Education: $77.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,993.58 |
| Travel and Lodging | $4,991.17 |
| Education | $77.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,288.89 | 2019-2025 | Arthrex, Arthroplasty Implants Anatomic Total Shoulder Eclipse |
| Cornerstone Medical Associates, INC. | $3,081.00 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $1,783.74 | 2019-2025 | Psi Knee, Persona, Mymobility Platform |
| Treace Medical Concepts, INC. | $1,146.79 | 2021 | |
| Micromed INC | $843.36 | 2021-2022 | |
| Linvatec Corporation | $298.03 | 2019 | |
| Smith+Nephew, INC. | $223.12 | 2020-2022 | |
| Depuy Synthes Sales INC. | $201.48 | 2019-2022 | |
| Embody, INC. | $113.09 | 2022 | |
| Stryker Corporation | $97.75 | 2023 | Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation, Mako |
| Medical Device Business Services, INC. | $82.20 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $68.07 | 2020-2024 | Iovera, Zilretta, Exparel |
| Naviswiss, INC. | $44.61 | 2024 | Naviswiss Hip Navigation |
| Bone Support INC. | $28.10 | 2024 | Ceramentbone Void Filler, Cerament G |
| Baudax Bio INC. | $24.66 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $22.95 | 2025 | Zynrelef |
| Biocomposites INC | $14.57 | 2021 | |
| Vericel Corporation | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.